Sentences with phrase «year program requires»

This two year program requires successful completion of 180 credits.

The Master of Science in Special Education is a part - time, two - year program requiring 32 — 37 credit hours.

The MFA at Vanderbilt is a two - year program requiring four semesters of graduate work in writing workshops and seminars.

Not exact matches

The M.N. Nurse Practitioner program at the University of British Columbia, home to one of the top ranked undergraduate nursing programs in the country, requires applicants to have at least three years of clinical experience and a well - demonstrated ability to act autonomously — a critical skill for primary care practitioners.

Unlike Waterloo's program, you can't apply directly from high school — this program requires students to take a qualifying first year before specializing.

He added, «It's a simple concept that's been advocated for years and is based on enforcement of our immigration laws that includes requiring employers to use the federal E-Verify program.

The usual academic process, Barbier noted, often requires students to spend years in the classroom before they actually get to program, a contention that Garcia backed up.

Airline frequent flier programs have become less rewarding over the last few years by offering fewer upgrades to elite fliers and requiring more miles than ever for award tickets.

While two - year full - time programs such as Tuck, Harvard, Stanford, Wharton, etc., require a significant investment in time and money, that investment pays off in both career options and compensation.

The most famous sect of the rules is set to take effect later this year, and would require wireline and mobile ISPs like Comcast and AT&T to ensure customers opt - in to any programs that share their web browsing and app usage histories, mobile location data, financial data, and other «sensitive» info with third parties for marketing purposes.

The 16 - month program requires two years of work experience and offers an accelerated option and a malleable schedule for part - time students.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

How to qualify: A registered nurse requires a bachelor of science in nursing, or a bachelor of nursing degree, both typically four - year programs.

Many IT program managers are required to have years of experience supporting technology projects as well as a bachelor's degree.

All candidates for the program will be required to pass the EDT, unless they have already written a Graduate Management Admission Test (GMAT) within the last 5 years and achieved a minimum score of 500 or the equivalent in the GRE.

In developing the National OCS Program, which has also been known as a Five Year Program, the Secretary is required to achieve an appropriate balance among the potential for environmental impacts, for discovery of oil and gas, and for adverse effects on the coastal zone.

Relevant degree, four + years» relevant experience, programming expertise required.

Each loan forgiveness program requires years of on - time payments before loan balances are forgiven, so it is important for borrowers to weigh the pros and cons of career decisions in advance.

However, it has been many years since there was a full review of the SR&ED Program, which is clearly required at this point.

This program requires that students pay back the first 120 payments (which turns out to be ten years) of their loan.

Companies could be required to file an initial submission when their projects or programs are conceived or started (or shortly thereafter) and to submit annual updates with their year end returns.

The «under» spending or lapse for 2010 - 11 and 2011 - 12 was usually large given that the funds earmarked for the various stimulus programs under the Economic Action Plan were not all required in that year.

The US Global Change Research Program is required by statute to produce the comprehensive National Climate Assessment report on climate change impacts on the United States every four years.

Complete the required 4 years of teaching within 8 years of completing or otherwise leaving your TEACH Grant eligible program of study.

Each year a batch of international founders will go through a fixed - period, cohort - based program where they will receive the mentoring and partnerships required to launch their businesses right here in Canada.

NOTE: Payments you make under a 10 - year Standard Repayment Plan or under any other Direct Loan Program repayment plan with payments that are at least equal to what you would have been required to pay under the 10 - year Standard Repayment plan also count toward PSLF.

You complete your TEACH Grant eligible program of study, but you do not begin or do not maintain qualifying employment within a timeframe that would allow you to complete your required 4 years of teaching within the 8 - year period described in your Agreement to Serve.

It's an enticing free upfront three - year package, bundling together software, support and promotion for no upfront cost — requiring merely a $ 100 payment when you leave the program.

Four years ago, as a result of a $ 200 million discrimination settlement, Coca - Cola was required by the court to set up an outside task force to monitor the progress of its diversity program.

For more than 50 years, the program for the poor and sick has been required to ferry certain clients to and from medical appointments.

The VA loan program for manufactured housing requires five percent down, and the loan terms are shorter — between 20 and 25 years, depending on the property.

Ottawa has also proposed to the provinces that the program could be phased in, with only a required 10 per cent implementation in its first year, beginning on April 1, 2014.

This is made of two parts: statutory programs under which authority for spending is granted through existing / enabling legislation and vote / appropriated spending for which Parliamentary approval is required each year.

And when you teach beyond the initial two - year term required, you get access to extra programs.

... our program required 4 years of Greek...»

That's why our program required 4 years of Greek — there's a much better chance of getting good enough to really * stay * good at that point.

Then, when I entered the Master of Divinity Program at Denver Seminary, I barely missed the required 70 % on the entrance exam, and so had to retake first year Greek again.

Except for an independent organization called the National Episcopal Coalition on Alcoholism and Drugs, a handful of diocesan, councils that promote conferences on alcohol and drugs, and approximately a dozen concerned and courageous bishops who require clergy training in the subjects, the Episcopal Church, in which I am a priest, would have no focused program on chemical dependency at all, save one day a year called Alcohol Awareness Sunday.

Instead of having to ascertain their local community's needs and interests every three years and then planning how their station would program to meet those needs, the broadcaster was now required only to send a post card each year to the Commission, stating weather or not they had met the community's needs!

My daughter is in her bat mitzvah year and as a part of the program we are required to bring desserts for the oneg table and every Saturday morning when there is a service, I wake up and think «aaackkk, I forgot again!»

And he did so with a social conscience: In 1987, 15 years before the establishment of the Rooney Rule (requiring NFL teams to interview at least one minority candidate for head coaching vacancies), Walsh took the lead in an NFL internship program for minority coaches, bringing prospective assistants into training camp each year and giving them significant responsibility.

If that isn't enough, Adu's accelerated high school program set up by IMG, the Edison Academic Center — through which he will earn his diploma next month — has included community service at a child - care center, which requires another form of superhero work: taking three - year - olds to the bathroom.

It helps now that Peak has her on a less rigid training program that allows her to play field hockey at school and requires only one - a-day workouts for part of the year.

Until recently, the ESA program required students to be either rising kindergarteners or first - graders, or to have been enrolled in a North Carolina public school during the school year prior to the one in which they planned to utilize the ESA.

Contrary to what you may have been reading, however, the exercise by municipalities of the power of the permit to require private sports programs to comply with state - mandated concussion safety laws, or impose additional conditions beyond those required by state law, isn't an isolated or new phenomenon: it's been a growing trend for years.

Answer: It is true, as I have learned from my own experience working with sensor companies and football programs the last four years, that a sensor program requires a considerable time committment.

State Board of Education Rule 160 -5-6-.01 (2011) require all new employees to complete, within the first year of employment, an employment training program.

This document is required before the LEA may renew their Agreement with the state agency to administer the federally - funded Child Nutrition Programs for the upcoming year.

Concussion or Sports Related Head Injury: HB 2273 (2012) requires the department of education and the Hawaii High School Athletic Association to develop a concussion educational program for students and student athletes 14 - 18 years old.

The program must require the testing of a statistically significant number of students multiple times throughout the year at approximately 30 percent of high schools that participate in athletic competitions sponsored by the League.